Erratum (DOI:10.1016/j.juro.2009.02.116);Multiple Adverse Histological Features Increase the Odds of Under Staging T1 Bladder Cancer

Journal of Urology

Volumn 182, Issue 1, 2009, Pages 59-65

  Weizer, Alon Z ^a   Wasco, Matthew J ^a   Wang, Rou ^a   Daignault, Stephanie ^b   Lee, Cheryl T ^a   Shah, Rajal B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

cystectomy; pathology; urinary bladder neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; CYSTECTOMY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL;

EID: 67349158889     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.005     Document Type: Erratum

References (18)

1. Herr H.W. Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome. Br J Urol 80 (1997) 762
2. Lee C.T., Dunn R.L., Ingold C., Montie J.E., and Wood Jr. D.P. Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion. Urology 69 (2007) 1068
3. Schrier B.P., Hollander M.P., van Rhijn B.W., Kiemeney L.A., and Witjes J.A. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 45 (2004) 292
4. Morris D.S., Weizer A.Z., Ye Z., Dunn R.L., Montie J.E., and Hollenbeck B.K. Understanding bladder cancer death: tumor biology versus physician practice. Cancer 115 (2009) 1011
5. Hollenbeck B.K., Miller D.C., Taub D., Dunn R.L., Underwood III W., Montie J.E., et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 64 (2004) 292
6. Kamat A.M., Dinney C.P., Gee J.R., Grossman H.B., Siefker-Radtke A.O., Tamboli P., et al. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 110 (2007) 62
7. Lerner S.P., Tangen C.M., Sucharew H., Wood D., and Crawford E.D. Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. Urol Oncol (2008) Feb 22 [Epub ahead of print]
8. Orsola A., Trias I., Raventos C.X., Español I., Cecchini L., Búcar S., et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 48 (2005) 231
9. Black P.C., Brown G.A., and Dinney C.P. Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer. J Clin Oncol 24 (2006) 5528
10. Lambert E.H., Pierorazio P.M., Olsson C.A., Benson M.C., McKiernan J.M., and Poon S. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. BJU Int 100 (2007) 33
11. Montie J.E., Abrahams N.A., Bahnson R.R., Eisenberger M.A., El-Galley R., Herr H.W., et al. Bladder cancer. Clinical guidelines in oncology. J Natl Compr Canc Netw 4 (2006) 984
12. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162 (1999) 74
13. Lee C.T., Madii R., Daignault S., Dunn R.L., Zhang Y., Montie J.E., et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 175 (2006) 1262
14. Epstein J.I., Amin M.B., Reuter V.R., and Mostofi F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22 (1998) 1435
15. Wasco M.J., Daignault S., Zhang Y., Kunju L.P., Kinnaman M., Braun T., et al. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 70 (2007) 69
16. Shen S.S., Lerner S.P., Muezzinoglu B., Truong L.D., Amiel G., and Wheeler T.M. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 37 (2006) 726
17. Cheng L., Neumann R.M., Weaver A.L., Spotts B.E., and Bostwick D.G. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 17 (1999) 3182
18. Paner G.P., Ro J.Y., Wojcik E.M., Venkataraman G., Datta M.W., and Amin M.B. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 31 (2007) 1420